Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro

Blood

Volumn 93, Issue 6, 1999, Pages 2057-2066

  Shiohara, Masaaki ^b   Dawson, Marcia I ^b   Hobbs, Peter D ^b   Sawai, Nobukuni ^b   Higuchi, Tsukasa ^b   Koike, Kenichi ^b   Komiyama, Atsushi ^b   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID A; RETINOID B; RETINOID C; RETINOID D; RETINOID DERIVATIVE; RETINOID E; RETINOID X RECEPTOR; SR 11276; SR 11278; SR 11302; SR 11345; SR 11363; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN HL 60; DRUG EFFECT; DRUG MECHANISM; DRUG PROTEIN BINDING; GROWTH INHIBITION; HEMATOPOIETIC CELL; LEUKEMIA CELL; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY;

EID: 0033559654     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.6.2057.406k04_2057_2066     Document Type: Article

References (51)

1. Koeffler HP: Induction of differentiation of human acute myelogenous leukemia cells: Therapeutic implication. Blood 62:709, 1983
2. Sporn MB, Roberts AB, Goodman DS: The Retinoids. Biology, Chemistry, and Medicine (ed 2). New York, NY, Raven, 1994
3. Breitman TR, Selonick SE, Collins SJ: Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77:2936, 1980
4. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu HT, Wang ZY: Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567, 1988
5. Chomienne C, Ballarini P, Balitrand N, Amar M, Bernard JF, Boivin P, Daniel MT, Berger R, Castaigne S, Degos L: Retinoic acid therapy for acute promyelocytic leukemia. Lancet 1:746, 1989
6. Douer D, Koeffler HP: Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 138:193, 1982
7. Douer D, Koeffler HP: Retinoic acid; inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 69:277, 1982
8. Douer D, Koeffler HP: Retinoic acid enhances growth of human early progenitor cells in vitro. J Clin Invest 69:1039, 1982
9. Giguere V, Ong ES, Segui P, Evans RM: Identification of a receptor for the morphogen retinoic acid. Nature 330:624, 1987
10. Petkovich M, Brand NJ, Krust A, Chambon P: A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330:444, 1987
11. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM: A nuclear receptor that identifies a novel retinoic acid receptor pathway. Nature 345:224, 1990
12. Leid M, Kastner P, Lyons R, Nakshatri H, Saunders M, Zacharewski T, Chen JY, Staub A, Gamier JM, Mader S, Chambon P: Purification, cloning, and RXR identify of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68:377, 1992
13. Umesono K, Murakami KK, Thompson CC, Evans RM: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255, 1991
14. Mangelsdorf DJ, Umesono K, Kllewer SA, Borgmeyer U, Ong ES, Evans RM: A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell 66:555, 1991
15. Kliewer SA, Umesono K, Heyman RA, Mangelsdorf DJ, Dyck JA, Evans RM: Retinoid X receptor-COUP-TF interactions modulate retinoic acid signaling. Proc Natl Acad Sci USA 89:1448, 1992
16. Yang N, Schule R, Mangelsdorf DJ, Evans RM: Characterization of DNA binding and retinoic acid binding properties of the retinoic acid receptor. Proc Natl Acad Sci USA 88:3559, 1992
17. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen CL, Rosenberger M, Lovey A, Grippo JF: 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 355:359, 1992
18. Heyman RA, Mangelsdorf DJ, Dick JA, Stein RB, Eichele G, Evans RM, Thaller C: 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397, 1992
19. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tomosaki R, Cameron JF, Dawson MI, Koeffler HP: 9-cis-retinoic acid: Effects on normal and leukemic hematopoiesis in vitro. Blood 81:1009, 1993
20. Kizaki M, Nakajima H, Mori S, Koike T, Morikawa M, Ohta M, Saito M, Koeffler HP, Ikeda Y: Novel retinoic acid, 9-cis retinoic acid, in combination with all-trans retinoic acid is an effective inducer of differentiation of retinoic acid-resistant HL-60 cells. Blood 83:3289, 1994
21. Kizaki M, Dawson MI, Heyman R, Elstner E, Morosetti R, Pakkala S, Chen D-L, Ueno H, Chao W-R, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP: Effects of novel retinoid X receptor-selective ligands on myeloid leukemic differentiation and proliferation in vitro. Blood 87:1997, 1996
22. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R: NB4, a maturation inducible cell line with t(15:17) marker isolated from a human acute promyelocytic leukemia (3M). Blood 77:1080, 1991
23. Bennet JM, Catavsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103:620, 1985
24. Dawson MI, Elstner E, Kizaki M, Chen D-L, Pakkala S, Kerner B, Koeffler HP: Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway. Blood 84:446, 1994
25. Lehmann JM, Zhang X-K, Pfahl M: RARγ2 expression is regulated through a retinoic acid response element embedded in Sp1 sites. Mol Cell Biol 12:2976, 1992
26. Lehmenn JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI, Pfahl M: Retinoids selective for retinoid X receptor response pathways. Science 258:1944, 1992
27. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
28. Chumakov AM, Grillier I, Chumakova E, Chih D, Slater J, Koeffler HP: Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor. Mol Cell Biol 17:1375, 1997
29. Shiohara M, Akashi M, Gombart AF, Yang R, Koeffler HP: Tumor necrosis factor α: Posttranscriptional stabilization of WAF1 mRNA in p53-deficient human leukemic cells. J Cell Physiol 166:568, 1996
30. Chen Z-X, Breitman TR: Tributyrin: A prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res 54:3494, 1994
31. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu X-P, Pfahl M: A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107, 1994
32. Antonson P, Stelleon P, Yamanaka R, Xamhopoulos KG: A novel human CCAAT/enhancer binding protein gene, C/EBP-∈, is expressed in cells of lymphoid and myeloid lineages and is localised on chromosome 14q11.2 close to the T-cell receptor α/δ locus. Genomics 35:30, 1996
33. Hunter T: Braking the cycle. Cell 75:839, 1993
34. Sherr CJ: G1 phase progression: Cycling on cue. Cell 79:551, 1994
35. Nurse P: Ordering S phase andMphase in the cell cycle. Cell 79:547, 1994
36. Hirama T, Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
37. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
38. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge S: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805, 1993
39. El-Deiry WS, Tokino T, Velculescu V, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potent mediator of p53 tumor suppression. Cell 75:817, 1993
40. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90, 1994
41. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
42. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59, 1994
43. Hashimoto Y, Petkovic M, Gaub MP, Kagechika H, Shudo K, Chambon P: The retinoic acid receptors alpha and beta are expressed in the human promyelocytic leukemia line HL-60. Mol Endocrinol 3:1046, 1989
44. Kizaki M, Ikeda Y, Tanosaka R, Nakajima H, Morikawa M, Sakashita A, Koeffler HP: Effects of novel retinoic acid compound, 9-cis retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor (RAR)-α and retinoid X receptor (RXR)-α RNA by HL-60 cells. Blood 82:3592, 1993
45. Nagy L, Thomazy VA, Shipley GL, Fesus L, Lamph W, Heyman RA, Chandraratna RAS, Davies PJA: Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 15:3540, 1995
46. Scott LM, Civin CI, Rorth P, Friedman AD: A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725, 1992
47. Cao Z, Umek RM, McKnight SL: Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538, 1991
48. Friedman AD, Landschulz WH, McKnight SL: CCAAT/ enhancer binding protein activates the promotor of the serum albumin gene in cultured hepatoma cells. Genes Dev 3:1314, 1989
49. Chih DY, Chumakov AM, Park DJ, Silla AG, Koeffler HP: Modulation of mRNA expression of a novel human myeloid-selective CCAAT/enhancer binding protein gene (C/EBP∈). Blood 90:2987, 1997
50. Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P: Inhibition of rumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 59:126, 1994
51. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52:2236, 1992